EAMS scientific opinion: Avalglucosidase alfa in the treatment of Pompe disease

This scientific opinion is issued for avalglucosidase alfa in the treatment of late- and infantile-onset Pompe disease for patients who have already received enzyme replacement therapy with alglucosidase alfa.

Source:

Medicines and Healthcare products Regulatory Agency